Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.477
-0.023 (-4.64%)
Feb 19, 2025, 3:58 PM EST
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $534.14 million as of February 19, 2025. Its market cap has increased by 184.52% in one year.
Market Cap
534.14M
Enterprise Value
537.12M
Revenue
70.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.48
Market Cap Chart
Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 534.14M, an increase of 5,478.32%. That is a compound annual growth rate of 16.32%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 2.16B |
SS Innovations International | 1.72B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 907.21M |
Glass House Brands | 493.69M |
Northwest Biotherapeutics | 328.28M |
CytoDyn | 266.89M |
BioStem Technologies | 248.15M |